Tr. Ulich et al., KERATINOCYTE GROWTH-FACTOR IS A GROWTH-FACTOR FOR TYPE-II PNEUMOCYTESIN-VIVO, The Journal of clinical investigation, 93(3), 1994, pp. 1298-1306
Keratinocyte growth factor (KGF) administered as a single intratrachea
l injection causes a prominent dose-dependent proliferation of type II
alveolar epithelial cells in the lungs of adult rats. The increase in
mitotically active alveolar cells histologically appears as a micropa
pillary epithelial cell hyperplasia after 2 d and peaks after 3 d in t
he form of monolayers of cuboidal epithelial cells lining alveolar sep
tae. Proliferating cell nuclear antigen immunohistochemistry confirmed
the profound proliferative response induced by KGF. The hyperplastic
alveolar lining cells contain immunoreactive surfactant protein B and
are ultrastructurally noted to contain lamellar inclusions characteris
tic of surfactant-producing type II pneumocytes. Mild focal bronchiola
r epithelial hyperplasia is noted but is much less striking than the p
roliferation of type II pneumocytes. Large airways are unaffected by K
GF. Daily intravenous injection of KGF is also able to cause pneumocyt
e proliferation. The normal adult rat lung constitutively expresses bo
th KGF and KGF receptor mRNA, suggesting that endogenous KGF may be im
plicated in the paracrine regulation of the growth of pneumocytes. In
conclusion, I(GF rapidly and specifically induces proliferation and di
fferentiation of type II pneumocytes in the normal adult lung.